Changqing Xie

13PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 03, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.

Hu Liang, Yao-Fei Jiang, Guo-Ying Liu

|Jan 06, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.

Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge

|Jun 23, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex.

Yilun Sun, Simone A Baechler, Xiaohu Zhang

|May 30, 2023
Reciprocal Interaction of Cancer Stem Cells of Cholangiocarcinoma with Macrophage.

Xin Wang, Jihye L Golino, Nga Voong Hawk

|May 22, 2023
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver.

Jyotsna Gummadi, Xin Wang, Changqing Xie

|May 13, 2023
Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma.

Jihye L Golino, Xin Wang, Jing Bian

Pageof 3

Frequent Collaborators

5 joint publications

Xin Wang

5 joint publications

Jihye Lee

3 joint publications

Cecilia Monge

3 joint publications

Tim F Greten